TLDR: Twin Health, a Silicon Valley-based metabolic health startup, has successfully raised $53 million in Series E funding, elevating its valuation to more than $950 million. The company leverages AI-driven digital twin technology to combat type 2 diabetes and related metabolic conditions, with clinical trials demonstrating significant success in disease reversal. This latest investment will primarily support Twin Health’s strategic expansion, particularly through collaborations with major employers and health plans.
Twin Health, a pioneering Silicon Valley-based startup focused on metabolic health, has announced the successful closure of a $53 million Series E funding round. This significant capital injection pushes the company’s valuation beyond $950 million. The round was spearheaded by Danish investment firm Maj Invest, with continued participation from existing investors Iconiq and Temasek.
The core of Twin Health’s innovative approach lies in its AI-driven digital twin technology. This platform creates a personalized virtual replica of an individual’s body, integrating data from various sources including the internet of things (IoT) and other digital technologies. The aim is to gain a precise understanding of metabolic dysfunction, which is identified as the root cause of conditions like type 2 diabetes, and then to guide interventions to repair it.
The efficacy of Twin Health’s platform has been underscored by compelling clinical outcomes. A study, led by the Cleveland Clinic and published in the New England Journal of Medicine Catalyst, reported that 71% of participants utilizing Twin Health’s platform achieved an A1C level below 6.5%, effectively normalizing their blood sugar to non-diabetic levels. This also led to a reduction in medication use among participants. The company highlights a notable success story of a user who, through the AI-powered platform, lost 70 pounds and normalized blood sugar within 90 days.
With the newly secured funds, Twin Health plans to accelerate its expansion efforts. A key focus will be forging partnerships with large employers and health plans, enabling the company to scale its AI-powered health platform across the United States.
Also Read:
- Wellth Raises $36 Million in Series C Funding to Advance AI-Powered Health Behavior Platform
- EliseAI Secures $250 Million Series E Funding to Propel AI Automation in Healthcare and Housing
Headquartered in Mountain View, California, Twin Health has steadily grown its financial backing. Prior to this Series E, the company had completed a Series D round in October 2023, a Series C in December 2021, a Series B in October 2020, a Series A that raised $18 million, and an initial Seed round of $2 million. The company also holds patents related to ‘Precision biology search with machine learning and digital twin technology,’ further solidifying its position as an innovator in the health technology space.
